Search

19 Jun 2024: class="field-label">Credit:&nbsp;</div><div class="field-items"><div class="field-item even"><a href="http://www.acnr.co.uk/">Advances in Clinical Neuroscience and Rehabilitation ... for patients with relapsing-remitting multiple sclerosis.</p> <p>“The

19 Jun 2024: Rosemary obtained her BSc (Hons) in Applied Biology from Bath University, and PhD in Neuroscience at Cambridge (Wolfson, 1992-1995). ... Rosemary has been a Section Editor and Editor of the international neuroscience journal NeuroReport, and is currently

23 Feb 2024: The advances in treatment of multiple sclerosis seen in the last 20 years have been remarkable and unmatched by therapies developed for any other neurological disease,” said Compston. ... Photo credit: Advances in Clinical Neuroscience and

19 Jun 2024: 2004. Morton, A.J. (2004) Molecular pathogenesis in Huntington's disease. Advances in Clinical Neuroscience and Rehabilitation 4 (1) 9-11 Link. ... 2001) Motor co-ordination and balance in rodents. Current Protocols in Neuroscience pp 8.12.1-8.12.14 John

19 Jun 2024: She has been Editor of NeuroReport Journal and is currently a Section Editor for Advances in Clinical Neuroscience and Rehabilitation. ... Webb, J. “Moving Clinical education online”, in 2020-21 Michaelmas Cambridge Centre for Teaching and learning,

19 Jun 2024: Search site. Department of Physiology, Development and Neuroscience. Publications. Professor of Neurobiology and Director of Studies in Medicine and Veterinary Medicine, Newnham College. ... 2004. Morton, A.J. (2004) Molecular pathogenesis in

11 Mar 2015: The advances in treatment of multiple sclerosis seen in the last 20 years have been remarkable and unmatched by therapies developed for any other neurological disease,” said Compston. ... The American Academy of Neurology, an association of more than 28

31 Mar 2016: My research has two overarching aims:. 1) to employ systems neuroscience as a translational bridge between the molecular biology of dementia and targeted clinical trials. ... 2015 Aug;15(4):302-308. PMID: 2597206. Cope TE, Sedley W, Griffiths TD.

19 Jun 2024: above"><div class="field-label">Credit:&nbsp;</div><div class="field-items"><div class="field-item even"><a href="http://www.acnr.co.uk/">Advances in Clinical Neuroscience and Rehabilitation ... for patients with relapsing-remitting multiple sclerosis.</p

23 Feb 2024: 2020). Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies, International Journal of Clinical Pharmacology Therapeutics, 58(8):426-438, doi: 10.5414/CP203705, PMID: ... T. (2019).